Small bowel adenocarcinoma of the jejunum

Rita Monteiro

doi:10.18203/2349-2902.isj20242768

Authors

Rita Monteiro General Surgery Department, Unidade Local de Saúde de Castelo Branco, Castelo Branco, Portugal

DOI:

https://doi.org/10.18203/2349-2902.isj20242768

Abstract

Jejunal adenocarcinoma is an unusual type of gastrointestinal malignancy. The symptoms are vague, such as abdominal pain, nausea, vomiting, and, in some cases, weight loss. Due to this vague presentation as well as lack of definitive imaging techniques, diagnosis tends to be delayed and patients typically present at later stages. We present a case of a patient who presented with acute onset abdominal pain. Imaging revealed the presence of a suspicious lesion of the jejunum, with a 3,6 extension. The patient underwent a laparoscopy segmental intestinal resection and omental lymph node resection. The lesion was a 3-cm mass at proximal jejunum. The jejunum adenocarcinoma is a rare neoplasm of the small bowel. The curative resection at the early stages is still the best treatment.

Metrics

Metrics Loading ...

References

Li J, Wang Z, Liu N, Hao J, Xu X. Small bowel adenocarcinoma of the jejunum: a case report and literature review. World J Surg Oncol. 2016;14:177.

Pedersen KS, Raghav K, Overman MJ. Small bowel adenocarcinoma: etiology, presentation, and molecular alterations. J Natl Compr Canc Netw. 2019;17:1135–41.

Rongviriyapanich A. Adenocarcinoma of jejunum. J Surg Case Rep. 2018;8:1-3.

Faivre J, Trama A, De Angelis R, Elferink M, Siesling S, Audisio R, et al. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002. Eur J Cancer. 2012;48:1417-24.

Agha RA, Borrelli MR, Farwana R, Koshy K, Fowler A, Orgill DP. For the SCARE group. The SCARE 2018 statement: updating consensus surgical case report (SCARE) guidelines. Int J Surg. 2018;60:132-6.

Lee HJ, Cha JM, Lee JI, Joo KR, Jung SW, Shin HP. A case of jejunal adenocarcinoma diagnosed by preoperative double balloon enteroscopy. Gut Liver 2009;3:311-4.

Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518-26.

Locher C, Batumona B, Afchain P, Carrère N, Samalin E, Cellier C, et al. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis. 2018;50:15.

Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Small bowel adenocarcinoma, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(9):1109-33.

Gleason D, Miller-Hammond KE, Gibbs JF. Surgical oncology: a practical and comprehensive approach. New York: Springer. Small bowel cancer. 2015:217-34.

Kumamoto K, Ishibashi K, Ishida H. Predictive marker for the efficacy of FOLFOX treatment in colon cancer (TS, ERCC1 etc.) Nihon Rinsho. 2011;69(3):494-9.

Speranza G, Doroshow JH, Kummar S. Adenocarcinoma of the small bowel: changes in the landscape? Curr Opin Oncol. 2010;22:387-93.